Clinical Trial Update: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating pemetrexed in combination with cisplatin and radiation therapy for esophageal and gastroesophageal junction cancer; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Platinol (cisplatin)

Snippet

Sponsor: University of Arizona | Conditions: Esophageal Cancer | Phase 1 | Status: COMPLETED